A detailed history of Long View Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Long View Wealth Management holds 4,569 shares of ABT stock, worth $525,389. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,569
Previous 4,469 2.24%
Holding current value
$525,389
Previous $464 Million 12.19%
% of portfolio
0.17%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$100.07 - $118.13 $10,007 - $11,813
100 Added 2.24%
4,569 $521 Million
Q2 2024

Jul 22, 2024

SELL
$100.73 - $112.44 $5,237 - $5,846
-52 Reduced 1.15%
4,469 $464 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $45,122 - $49,835
-412 Reduced 8.35%
4,521 $514 Million
Q4 2023

Jan 10, 2024

BUY
$90.19 - $110.4 $444,907 - $544,603
4,933 New
4,933 $556 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Long View Wealth Management Portfolio

Follow Long View Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long View Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Long View Wealth Management with notifications on news.